Further performing studies with a large patient cohort focusing on risk factors of stroke are however, necessary to examine additional biomarkers including VEGF and MCP-1 with reduced sample time after stroke onset to corroborate this preliminary data. The gene discussed is CCL2; the disease is stroke disorder.